FDA approves generic of dementia med Namenda… Seniors at 54% higher risk for readmission after surgery … Drug used to treat liver disease could slow Parkinson’s
House IPAB repeal advances
By
Elizabeth Newman
Aug 05, 2015
The House of Representatives voted in June to repeal the Independent Payment Advisory Board, a Medicare cost containment entity created under the Affordable Care Act.
State News for August 2015
Aug 05, 2015
The nation’s most populous state is also now home to the largest long-term care workers’ union, which formally chartered in late June.
Genesis will acquire 24 SNFs in $240 million Revera deal
By
Aug 05, 2015
Genesis Healthcare will acquire 24 skilled nursing facilities from Revera Inc., as part of a $240 million portfolio.
Coumadin, warfarin errors put residents at risk
By
Jul 14, 2015
New research shows improper use and lack of monitoring of popular blood thinners can put residents at risk for hospitalization, life-threatening injury and death.
Continuum is complete
By
John Andrews
Jul 06, 2015
Edgewood Summit builds a new memory care addition in order to fully round out its healthcare mission for West Virginia residents.
Genesis spends $240M on SNF portfolio
By
Holly Petrovich
Jun 16, 2015
Genesis HealthCare announced Monday it will acquire 24 of Revera Inc.’s skilled nursing facilities and rehabilitation business for $240 million.
Also in the News for Monday, June 15
Jun 15, 2015
Medicare favors generic opioid drug to avoid abuse … LTC plans use technology to reduce costs … Spinal cord injuries increase in older adults … More than half of seniors live below poverty...
Latest Alzheimer’s discovery looks like a real eye-opener
By
Kimberly Marselas
Jun 05, 2015
Extra sleep can help fruit flies overcome Alzheimer’s-like memory problems, according to new research out of Washington University School of Medicine in St. Louis.
Popular Alzheimer’s drug to remain on the market at least until August
By
John Hall
May 27, 2015
A federal appeals court has temporarily thwarted a drug company’s plan to replace a proven Alzheimer’s drug with a more expensive version.